Transcriptomic screening for drug discovery decisions.
Predictive molecular insights for chemical safety and sustainable products.
Democratizing transcriptomics for every lab, every organism.
Extraction-free, high-throughput bulk RNA-seq directly on cells—no tedious RNA isolation. Ideal for pre-clinical drug discovery. Profile thousands of compounds or conditions in a single experiment to accelerate hit ID, map mechanisms of action, predict off-targets, and surface toxicity signals earlier.
Access single-cell sensitivity that droplet methods cannot provide. Our full-length plate-based single-cell RNA-seq captures rare or low-input cells with confidence. Simplified automation-friendly workflow for low-count sorted cells and low-input RNA.
Up to 384 library preps in one single tube.
Our highly optimized sets of barcoded primers are used to “tag” individual RNA samples in a unique and sample-specific manner during the first step of the library preparation workflow. Samples can then be pooled and processed together in one single tube.
Skip RNA extraction. Go straight to library prep.
We developed an optimized cell lysis buffer to support efficient lysis directly from frozen cell pellets. Move from lysate to library preparation without RNA extraction, helping preserve valuable material and reduce handling.
From purified RNA to cell and organoid lysates.
From single cells to bulk RNA samples, our solutions accommodate a wide range of inputs.
From 3' to full-length and total RNA sequencing.
Our massively multiplexed and extraction-free solutions are compatible with diverse sequencing options.
Purified RNA
Extraction-freeWhether you are comparing technologies or fine-tuning doses, our experts can help you turn ideas into a robust experimental plan.
Biomarker discovery using gene expression signatures has transformed pharmaceutical discovery and development, from early hit triage and target validation to toxicology, dose optimization, and patient…
Next-generation AI models for drug discovery are only as powerful as the quality, size, and perturbation-richness of their training data. Yet no publicly available dataset…
As the SOT Annual Meeting and ToxExpo 2026 approaches, we take a pre-conference look at the program through a transcriptomics-focused lens. One overall shift is…
Tell us about your project and we will help you find the right approach.
